190 related articles for article (PubMed ID: 37540330)
1. ELABELA/APJ Axis Prevents Diabetic Glomerular Endothelial Injury by Regulating AMPK/NLRP3 Pathway.
Chen Z; Wang Z; Hu Y; Lin H; Yin L; Kong J; Zhang Y; Hu B; Li T; Zheng X; Yang Q; Ye S; Wang S; Zhou Q; Zheng C
Inflammation; 2023 Dec; 46(6):2343-2358. PubMed ID: 37540330
[TBL] [Abstract][Full Text] [Related]
2. ELABELA attenuates deoxycorticosterone acetate/salt-induced hypertension and renal injury by inhibition of NADPH oxidase/ROS/NLRP3 inflammasome pathway.
Chen Z; Wu C; Liu Y; Li H; Zhu Y; Huang C; Lin H; Qiao Q; Huang M; Zhu Q; Wang L
Cell Death Dis; 2020 Aug; 11(8):698. PubMed ID: 32829380
[TBL] [Abstract][Full Text] [Related]
3. Omarigliptin ameliorated high glucose-induced nucleotide oligomerization domain-like receptor protein 3 (NLRP3) inflammasome activation through activating adenosine monophosphate-activated protein kinase α (AMPKα) in renal glomerular endothelial cells.
Li L; Qian K; Sun Y; Zhao Y; Zhou Y; Xue Y; Hong X
Bioengineered; 2021 Dec; 12(1):4805-4815. PubMed ID: 34338149
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis.
Wu Q; Guan YB; Zhang KJ; Li L; Zhou Y
J Ethnopharmacol; 2023 Nov; 316():116667. PubMed ID: 37257702
[TBL] [Abstract][Full Text] [Related]
5. Apelin-13/APJ system attenuates early brain injury via suppression of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation and oxidative stress in a AMPK-dependent manner after subarachnoid hemorrhage in rats.
Xu W; Li T; Gao L; Zheng J; Yan J; Zhang J; Shao A
J Neuroinflammation; 2019 Dec; 16(1):247. PubMed ID: 31791369
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
7. Loganin reduces diabetic kidney injury by inhibiting the activation of NLRP3 inflammasome-mediated pyroptosis.
Kong X; Zhao Y; Wang X; Yu Y; Meng Y; Yan G; Yu M; Jiang L; Song W; Wang B; Wang X
Chem Biol Interact; 2023 Sep; 382():110640. PubMed ID: 37473909
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV ameliorates diabetic nephropathy in
Feng H; Zhu X; Tang Y; Fu S; Kong B; Liu X
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278447
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia aggravates acute liver injury by promoting liver-resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR-mediated autophagy induction.
Wang Q; Wei S; Zhou S; Qiu J; Shi C; Liu R; Zhou H; Lu L
Immunol Cell Biol; 2020 Jan; 98(1):54-66. PubMed ID: 31625631
[TBL] [Abstract][Full Text] [Related]
10. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys.
Hou Y; Wang Q; Han B; Chen Y; Qiao X; Wang L
Cell Death Dis; 2021 May; 12(6):523. PubMed ID: 34021126
[TBL] [Abstract][Full Text] [Related]
11. Ticagrelor and Dapagliflozin Have Additive Effects in Ameliorating Diabetic Nephropathy in Mice with Type-2 Diabetes Mellitus.
Birnbaum Y; Chen H; Tran D; Nylander S; Ye Y
Cardiovasc Drugs Ther; 2022 Oct; 36(5):829-840. PubMed ID: 34232433
[TBL] [Abstract][Full Text] [Related]
12. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
Lv C; Cheng T; Zhang B; Sun K; Lu K
Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
[No Abstract] [Full Text] [Related]
13. Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction.
Chen Y; Wang L; Pitzer AL; Li X; Li PL; Zhang Y
J Mol Med (Berl); 2016 Dec; 94(12):1335-1347. PubMed ID: 27783111
[TBL] [Abstract][Full Text] [Related]
14. Salidroside alleviates diabetic neuropathic pain through regulation of the AMPK-NLRP3 inflammasome axis.
Zheng T; Wang Q; Bian F; Zhao Y; Ma W; Zhang Y; Lu W; Lei P; Zhang L; Hao X; Chen L
Toxicol Appl Pharmacol; 2021 Apr; 416():115468. PubMed ID: 33639149
[TBL] [Abstract][Full Text] [Related]
15. Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy.
Yang F; Qin Y; Wang Y; Meng S; Xian H; Che H; Lv J; Li Y; Yu Y; Bai Y; Wang L
Int J Biol Sci; 2019; 15(5):1010-1019. PubMed ID: 31182921
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 inflammasome-mediated endothelial cells pyroptosis is involved in decabromodiphenyl ethane-induced vascular endothelial injury.
Zheng D; Shi Z; Yang M; Liang B; Zhou X; Jing L; Sun Z
Chemosphere; 2021 Mar; 267():128867. PubMed ID: 33187650
[TBL] [Abstract][Full Text] [Related]
17. Ras guanine nucleotide-releasing protein-4 promotes renal inflammatory injury in type 2 diabetes mellitus.
Huang S; Wang J; Zhang L; Tian S; Wang Y; Shao X; Zhou S; Yu P
Metabolism; 2022 Jun; 131():155177. PubMed ID: 35218794
[TBL] [Abstract][Full Text] [Related]
18. Schisandrin A from Schisandra chinensis Attenuates Ferroptosis and NLRP3 Inflammasome-Mediated Pyroptosis in Diabetic Nephropathy through Mitochondrial Damage by AdipoR1 Ubiquitination.
Wang X; Li Q; Sui B; Xu M; Pu Z; Qiu T
Oxid Med Cell Longev; 2022; 2022():5411462. PubMed ID: 35996380
[No Abstract] [Full Text] [Related]
19. Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE
Tang G; Duan F; Li W; Wang Y; Zeng C; Hu J; Li H; Zhang X; Chen Y; Tan H
Biomed Pharmacother; 2019 Nov; 119():109410. PubMed ID: 31518877
[TBL] [Abstract][Full Text] [Related]
20. Punicalagin Protects Diabetic Nephropathy by Inhibiting Pyroptosis Based on TXNIP/NLRP3 Pathway.
An X; Zhang Y; Cao Y; Chen J; Qin H; Yang L
Nutrients; 2020 May; 12(5):. PubMed ID: 32456088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
